AMPLA PHARMACEUTICALS INC — Form D/A
AMPLA PHARMACEUTICALS INC of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2013-02-28. The offering totals $5.4M, of which $3.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-02-28
- Form: D/A
- Accession: 0001381508-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $5.4M
- Amount sold: $3.6M
- Remaining: $1.8M
- Investors: 6
- Date of first sale: 2010-01-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-96858
Issuer
- Name: AMPLA PHARMACEUTICALS INC
- CIK: 0001381508
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: C/O ADVENT HEALTHCARE VENTURES, BOSTON, MA, 02110
- Phone: 858-551-8294
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Charles Cohen | Director | Cambridge, MA |
| Jason Fisherman | Director | Woodbridge, CT |
| Charles Cohen | Executive Officer | Cambridge, MA |
| Eric Bednarski | Director | Boston, MA |
| Jerry Wisler | Director | La Jolla, CA |
| James Hauske | Director | La Jolla, CA |
| James Hauske | Executive Officer | La Jolla, CA |
Other filings by this issuer (2)
More